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1. Side effects of therapy or chemotherapy 41(36.6%)
2. Procedures (Bone Marrow Aspiration, Hickman Line
insertion etc) 39(34.8%)
3. Infection Control 48(42.8%)
4. Sexuality 9(8%)
5. Fertility 11(9.8%)
6. Results of diagnostic test 59(52.7%)
7. others, blood tests 7(6.2%)
On discharge
1. Outcome of your treatment 65(58%)
2. Follow up, appointment 102(91%)
3. Medication 108(96.4%)
4. What happens next 88(78.5%)
5. When to call the medical team (Hospital) 94(83.9%)
6. Work life 68(60.7%)
7. Other alternative treatment regimens 8(7.1 %)
Total 112 (100%)
Findings & Interpretation: 112 malignant haematology
patients were admitted to our unit for various reasons Our
audit was evaluated in three different stages. The admission
stage; most of the information provided regarded side effects
of treatment and test results (See Table I). Our audit has
shown that, the admission stage was the lowest in terms of
information providing. It should be kept in mind that the
haematology patient group generally has a long hospital-
isation, the data collection tool was given on discharge.
Therefore, it was interpreted that data might be lost due to
poor recall of the information required. We are now giving
the data collection tool on admission rather than on
discharge in an effort to address this matter. Result showed
that Sexuality (9.8%) and fertility (11.6%) were the least
addressed topics; where as results of diagnostic test (43.7%)
was deemed the most important. On the other hand results
also showed our patient were happy about the information
they were given especially on discharge, as most aspects of
information was covered.
Discussion & Implications: For the haematology patient
group, knowing their diseases and potential outcomes does
help in the difﬁcult decision making process of their treat-
ment. Therefore as healthcare professionals it is our duty of
care to provide the information they need, but how far do we
need to go? This study was aimed at exploring our patient
groups information needs as well as providing a self per-
formance check. Our audit showed that our centre does
perform well in admission and discharge stages; we need to
work on the in patient period. In order to collect the required
data, we have decided to give patients the data collection
tool on admission rather than discharge.504
Can Platelet transfusion be unnecessary?
Serpil Vieira, Diane Monroe. The London Clinic, London,
United Kingdom
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Introduction Blood transfusion continues to be an essential
part of modern practise, but it is not without risk. During the
last decade there has been an increased interest across the
United Kingdom (UK) and Europe in collecting data on the
hazards of transfusion of blood components. Therefore
avoiding unnecessary transfusion is accepted as one way ofreducing the risk, which is associated with blood transfusion.
In our stem cell transplant unit we audited platelet trans-
fusion (PT).
Methods, Intervention, & Analysis: Method The audit was
carried out prospectively and retrospectively. The data was
validated and cross checked retrospectively, all inpatient
episodes were recorded on a monthly basis. The audit was
carried out over a 29 month period from May 2010 until the
end of September 2012. The duration was divided in three
periods in order to compare the outcome with our initial
audit.
Period I: 01/05/10- 31/10/10
Period II: 01/11/10- 30/09/11
Period III: 01/10/11- 30/09/12
Findings & Interpretation: Our unit policy is to keep the
platelet count at circa 10X109/L for uncomplicated inpatients
and at circa 20 x 109/L for complicated patients and out-
patients. We also aimed to keep platelet above 50 x 109/L if
patient is receiving anticoagulant or bleeding for various
reasons. In the comparison of the three periods, there was a
dramatic improvement in terms of reducing the unnecessary
platelet transfusion. As shown on Table 1, in period I 36% of
the transfusion occurred when plt> 31 x 109/L, where as on
period III, this ﬁgure dropped to 13.95. The reasons for un-
usual transfusion were bleeding, prior to invasive procedure
and anticoagulant use. As the ﬁgures are shown there was a
dramatic change in the period II and III compared with
period I regarding unnecessary platelet transfusion. It is also
highlighted the recent change in anticoagulant use due to
new VTE prophylaxis has caused in the numbers of platelet
transfusion when plt > 31X x 109/L. Even though there was
an increase due to VTE policy, the ﬁgures were still lower
than previous periods.
Discussion & Implications: Our organisation recognises the
importance of risk associated in unnecessary blood compo-
nent transfusion. Our audit has shown interesting ﬁgures.
The duration of audit was divided in three different periods
and outcomes compared. Between these three periods there
were dramatic changes as Table II shows. Our ﬁgures drop-
ped rapidly from 45.5% to 16.6% in platelet transfusion when
the platelet count was higher than 31 x109/L. There were
various reasons to transfuse platelets even though the count
was reasonable for the haematology patient group such as:
bleeding, prior to invasive procedure and anticoagulant use.505
Tranfuse or not to Transfuse?
Serpil Vieira, Diane Monroe. The London Clinic, London,
United Kingdom
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Blood transfusion continues to be an essential part of modern
practise but it is not without risk. During the last decade there
has been an increased interest across the United Kingdom
(UK) and Europe for collecting data on the hazards of trans-
fusion of blood components. Therefore avoiding unnecessary
transfusion is accepted as oneway of reducing the risk, which
is associated with blood transfusion. In our stem cell trans-
plant unit we have audited red cell transfusions. Our unit
policy is to keep the haemoglobin level above 8g/dL, this may
change from time to time and depends on the patient’s
clinical condition.
Methods, Intervention, & Analysis: The audit was carried
out prospectively and retrospectively. The datawas validated
and cross checked retrospectively, all inpatient data was
recorded on amonthly basis. The audit was carried out over a
period of 29 months from May 2010 until end of September
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was compared within these three periods.
Findings & Interpretation: Periods are shown in the table.
Comparison of these three periods have shown that during
period II a total of 240 episodes and the during period III 291
episode RCT were performed in our unit. It was almost same
ﬁgures in all of the three periods for necessary transfusion.
But there was a signiﬁcant increase in period III when Hb
levels are > 8.6 g/dL. The reason for transfusion was cat-
egorised as: routine, unit protocol, bleeding, pre procedure
and on doctor’s instruction due to patient symptoms or
keeping a high thresh hold haemoglobin level. Routine RCT
were 52.7% of total episodes in period II, 44% in period III
22.5% when Hb<8.0 g/dL. However 8.2% of the RCT trans-
fusions were given when haemoglobin levels were 9.1 g/dL
or higher in period II and 12.4% in period III. The ﬁgure was
10% in period I. The main reasons for transfusion when Hg >
10.1 g/dL were associated with the protocol regarding hyper
transfusing beta thalassemia major patient prior to trans-
plant in period I and II. In period III two patient were
symptomatic, therefore they required routine blood trans-
fusion when Hb >10 gr/L. Therefore it has resulted as an
increase in the blood transfusion when Hb is > 9.1g/dL.
Discussion & Implications: Our organisation recognises the
importance of risk associated in unnecessary blood compo-
nent transfusion. Our audit has shown interesting ﬁgures.
The audit was divided into three periods and outcomes
compared. Our ﬁgures showed that practice was improving
the ﬁrst two periods. There was a signiﬁcant increase in the
blood transfusionwhen Hb>10g/dL, this was due to a patient
being clinically symptomatic.506
BMT Boot Camp
Kathryn Walters, Piper Coleman, Laura Flesch. Cincinnati
Children’s Hospital Medical Center, Cincinnati, Ohio
Topic Signiﬁcance & Study Purpose/Background/Rationale:
The Specialty Resource Unit (SRU) is the ﬂoat pool servicing
the bone marrow transplant (BMT) unit when stafﬁng is low,
census and/or acuity is high. These nurses are expected to
provide specialized care to this complex and intensive patient
population within a 6 shift orientation. The BMT unit is SRU’s
introduction to critical care nursing. The complexity of care
required for this patient population is overwhelming to a ﬂoat
pool nurse coming onto the unit for the ﬁrst time.
Methods, Intervention, & Analysis: An assessment was
conducted on former ﬂoat orientees and BMT preceptors to
identify educational and supportive needs. The assessment
indicated an introductory education was needed prior to the
ﬂoat nurses starting on BMT. The BMT Boot Camp education,
which includes a lecture presentation and interactive
learning, provides an in-depth understanding of the
specialized BMT knowledge and skills. The presentation
provides knowledge from the beginning phase of BMT and
ending with the care required for patients to move toward
discharge. The interactive portion introduces complex line
management, high risk infusions, blood product adminis-
tration, and in depth central venous catheter care.
Findings & Interpretation: The program evaluations from
both preceptors and orientees speak favorably to the BMT
Boot Camp. Preceptors identiﬁed less “work time” instruc-
tion of the BMT process which allows more organizational
skill development and procedure experience. Float nurses
identiﬁed more conﬁdence, autonomy, andmore initiative to
provide independent care.Discussion & Implications: Providing specialty education
promotes comfort and conﬁdence in a highly specialized
unit. A BMT speciﬁc education class offers useful resources
and decreased anxiety for the ﬂoat nurses. It also offers an
opportunity for ﬂoat nurses to build a rapport with the BMT
preceptors. Through conﬁdence displayed by the ﬂoat staff,
parents of patients are more conﬁdent in the care the ﬂoat
nurse provide to their child.TRANSPLANT NURSING RESEARCH
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What is the Difference Between Inpatient BMT Patients
Who Fall vs Non-fallers: A Retrospective Study
Noel Arring, Travis Shelton. Mayo Clinic, Phoenix, Arizona
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Current research on inpatient falls has focused on themedical
surgical population. Research on falls is just starting to delve
into the difference between oncology patients who fall and
the medical surgical patient who fall and the different stra-
tegies for each. This research is a starting point to look further
into the oncology subpopulation and focus on the Hemato-
poietic Stem Cell Transplant (HSCT) patient. Speciﬁc research
on HSCT patient population is warranted because of addi-
tional risk factors for falls which includemyeloablative cancer
treatments, prolonged inpatient stays, debilitating weakness
and fatigue.
Methods, Intervention, & Analysis: This retrospective case-
controlled study will evaluate the difference between inpa-
tient HSCT patients who fell versus those HSCT Patients who
did not fall. This project is aimed at determining the inci-
dence of falls in our HSCT population and the factors that are
signiﬁcant in predicting falls in the hematopoietic cell
transplant population. This research project is analyzing
multiple variables including: conditioning regimens, source
of stem cells, medication usage, number of transplants,
ECOG, readmission vs. initial admission for transplant, and
length of stay with an aim at identifying variables that can be
used to identify HSCT patients at risk for falls and/or vari-
ables that can be controlled/changed to decrease risk for falls
in the inpatient unit.
Findings & Interpretation: We are at the preliminary phase
of this project and will present the multidisciplinary
approached used in this research project as well as our
preliminary ﬁndings.
Discussion & Implications: This research has the potential
to help identify those HSCT patients at risk for falls as well as
possible controllable variables that can be modiﬁed to
decrease the HSCT patients risk for falls. This retrospective
study is the ﬁrst phase of a larger project and is laying the
ground work for an intervention based prospective study in
the HSCT patient population.
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Stem Cell Transplant: Is There an App for That?
Yvonne Barnes, Cynthia Schmidt, Laura Bernaix. Southern
Illinois University Edwardsville, Swansea, Illinois
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Rationale: Stem cell transplant (SCT) can beneﬁt children
with various diseases. Numerous complications and/or short
and long term care needsmay occur. Historically, themajority
of SCT referrals were malignant disorders. This is changing
as many nonmalignant diseases (NM) are now considered
